RNA編集の市場規模は2023年に142億ドルと評価され、2024年の150億ドルから2032年までに226億ドルに成長し、予測期間 (2024年から2032年)の間に6.00%のCAGRを示すと予測されます。RNA治療薬の急速な拡大とゲノム編集アプリケーションの拡大が、市場の成長を促進する主要な市場推進要因です。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RNA EDITING MARKET, BY TYPE OF RNA
6.1. Overview
6.2. Messenger RNA Modification
6.3. Transfer RNA Modification
6.4. Ribosomal RNA Modification
7. GLOBAL RNA EDITING MARKET, BY APPLICATION
7.1. Overview
7.2. Cancer
7.3. Genetic Disorders
7.4. Temporary Maladies
8. GLOBAL RNA EDITING MARKET, BY TECHNIQUE
8.1. Overview
8.2. Insertion/ Deletion
8.3. Deamination
9. GLOBAL RNA EDITING MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global RNA Editing Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global RNA Editing Market
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. ProQR Therapeutics NV
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Sirna Therapeutics, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Shape Therapeutics, Inc
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. KORRO BIO, INC.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. BEAM THERAPEUTICS, INC.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. QIAGEN N.V
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. UniQure NV (UniQure)
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. LAVA THERAPEUTICS N.V.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. ARGENX SE
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Arrowhead Pharmaceuticals, Inc..
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RNA EDITING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL RNA EDITING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 9 US: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 10 US: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 US: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 12 CANADA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 13 CANADA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 10 ITALY: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 11 ITALY: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 ITALY: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 16 UK: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 17 UK: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 UK: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 28 CHINA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 29 CHINA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 CHINA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 31 INDIA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 32 INDIA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 INDIA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: RNA EDITING MARKET, BY TYPE OF RNA, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: RNA EDITING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: RNA EDITING MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RNA EDITING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RNA EDITING MARKET
FIGURE 4 GLOBAL RNA EDITING MARKET, SHARE (%), BY TYPE OF RNA, 2023
FIGURE 5 GLOBAL RNA EDITING MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL RNA EDITING MARKET, SHARE (%), BY TECHNIQUE, 2023
FIGURE 7 GLOBAL RNA EDITING MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: RNA EDITING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: RNA EDITING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: RNA EDITING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: RNA EDITING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL RNA EDITING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 PROQR THERAPEUTICS NV: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 PROQR THERAPEUTICS NV: SWOT ANALYSIS
FIGURE 15 SIRNA THERAPEUTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 SIRNA THERAPEUTICS, INC.: SWOT ANALYSIS
FIGURE 17 SHAPE THERAPEUTICS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 SHAPE THERAPEUTICS, INC: SWOT ANALYSIS
FIGURE 19 KORRO BIO, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 KORRO BIO, INC: SWOT ANALYSIS
FIGURE 21 BEAM THERAPEUTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 BEAM THERAPEUTICS, INC.: SWOT ANALYSIS
FIGURE 23 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 QIAGEN N.V.: SWOT ANALYSIS
FIGURE 25 UNIQURE NV (UNIQURE): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 UNIQURE NV (UNIQURE): SWOT ANALYSIS
FIGURE 27 LAVA THERAPEUTICS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 LAVA THERAPEUTICS N.V.: SWOT ANALYSIS
FIGURE 29 ARGENX SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 ARGENX SE: SWOT ANALYSIS
FIGURE 31 ARROWHEAD PHARMACEUTICALS, INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ARROWHEAD PHARMACEUTICALS, INC..: SWOT ANALYSIS
